Muktwelve: A Randomized Phase II Trial of Selinexor, Cyclophosphamide and Prednisolone Vs Cyclophosphamide and Prednisolone in Relapsed or Refractory Multiple Myeloma (RRMM) Patients

Details

Request a copyRequest a copy
Serval ID
serval:BIB_AC68E8EB63A4
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Production externe
Title
Muktwelve: A Randomized Phase II Trial of Selinexor, Cyclophosphamide and Prednisolone Vs Cyclophosphamide and Prednisolone in Relapsed or Refractory Multiple Myeloma (RRMM) Patients
Title of the conference
Blood
Author(s)
Brown Sarah R, Hall Andrew, Kendall Jessica, Ingleson Emma, Flanagan Louise, Auner Holger W, Boyd Kevin, Garg Mamta, Kaiser Martin F.
Publisher
American Society of Hematology
Organization
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Address
Orlando, FL
ISSN
0006-4971
1528-0020
Publication state
Published
Issued date
13/11/2019
Volume
134
Number
Supplement_1
Pages
5552-5552
Language
english
DOI
10.1182/blood-2019-123672
Web of science
000577164606270
Open Access
Yes
Create date
02/12/2024 16:49
Last modification date
04/12/2024 7:07
Usage data